Taysha Gene Therapies, Inc. (TSHA) - Total pendapatan perusahaan

Simbol lan logo merek Taysha Gene Therapies Inc (TSHA)

The overall sales level of Taysha Gene Therapies (TSHA) reflects demand dynamics, where the value remains at 0.01. Taysha Gene Therapies (TSHA) focuses on treating rare CNS pathologies, including Rett syndrome. Growth is driven by the accelerated rollout of breakthrough drugs for monogenic disorders. Intellectual property protection and orphan status create significant barriers for competitors in the gene therapy sector.

Taysha Gene Therapies, Inc. - Pendapatan lan volume dodolan TSHA (periode 04.07.2022 - 18.11.2026)

Rincian analitis perusahaan Taysha Gene Therapies, Inc. (TSHA)

- kuotasi saiki lan rata-rata prakiraan nilai:
- indikator kapitalisasi pasar:
Ringkesan analisis perusahaan:Taysha Gene Therapies - TSHA
Barang unggulan tayshagtx.com

Taysha Gene Therapies (TSHA) sales reflect actual daily revenue, allowing for an assessment of the issuer's resilience to inflationary shocks and interest rate changes. By analyzing the company's sales volume history, an investor can track the dynamics of cash inflows from product sales. This metric aggregates all operating income for the reporting period to determine market share. For Taysha Gene Therapies (TSHA), this figure remains minimal, as CNS gene therapy is currently in the clinical testing stage. Growth in this indicator is expected only after the commercialization of the drugs.

Pesaing wigati

Tempus AI, Inc. (TEM) - Pendapatan reged perusahaan|Dodolan perusahaan QGEN (Qiagen NV)|Pendapatan lan volume dodolan Ionis Pharmaceuticals, Inc. (IONS)|Pendapatan lan volume dodolan RGEN (Repligen Inc.)|Avidity Corp (RNA) - Total pendapatan perusahaan|CRSP - Pendapatan perusahaan|Pendapatan reged perusahaan genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Pendapatan perusahaan|Total pendapatan perusahaan Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Twist Bioscience Corp TWST|Pendapatan lan volume dodolan TXG|Pendapatan lan volume dodolan intelliatx.com (NTLA)|Stoke Therapeutics - Dodolan perusahaan|BioLife Solutions Inc (BLFS) - Total pendapatan perusahaan|wavelifesciences.com - Pendapatan lan volume dodolan|Maze Therapeutics Corp (MAZE) - Dodolan perusahaan|SION: Pendapatan lan volume dodolan|Volume dodolan perusahaan PRME|Pendapatan perusahaan uniQure Corp|MGTX: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan RGNX|Pendapatan reged perusahaan Solid Corp|Pendapatan lan volume dodolan OCGN (ocugen.com)|PACB (Pacific Biosciences) - Pendapatan tahunan perusahaan|Benitec Biopharma Inc - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Pendapatan perusahaan|4D Molecular Therapeutics (FDMT) - Pendapatan lan volume dodolan|LXEO (Lexeo Therapeutics, Inc.) - Pendapatan lan volume dodolan|Total pendapatan perusahaan korrobio.com KRRO|Dodolan perusahaan EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Volume dodolan perusahaan|Pendapatan perusahaan ProQR Therapeutics N.V. PRQR|Pendapatan reged perusahaan Codexis, Inc. (CDXS)|SGMO - Pendapatan perusahaan|nautilus.bio - Total dodolan perusahaan|Metagenomi, Inc (MGX) - Pendapatan perusahaan|Volume dodolan perusahaan DTIL|Pendapatan perusahaan Generation Bio|Pendapatan lan volume dodolan Boundless Bio Inc|Pendapatan perusahaan Exicure Corp (XCUR)|Pendapatan reged perusahaan Imunon|Pendapatan lan volume dodolan PHIO (phiopharma.com)|Total volume dodolan perusahaan mustangbio.com|RNAZ - Pendapatan perusahaan|Total pendapatan perusahaan Bionano Genomics|APDN: Pendapatan lan volume dodolan|Volume dodolan perusahaan BLUE|Dodolan perusahaan IPA|OMGA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan OMIC|Pendapatan reged perusahaan Regulus Therapeutics|Pendapatan perusahaan Syros SYRS|Pendapatan dodolan perusahaan TBIO|TCON: Dodolan perusahaan|Unity Biotechnology, Inc. (UBX) - Dodolan perusahaan